Company Overview
CARTESIAN THERAPEUTICS, INC.
RNACRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
3M
2025 FY
Net Income
-130M
2025 FY
Shares Outstanding
26M
2025 FY
EPS
-5.02USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1453687
Exchange
Nasdaq
Location
US